chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for the coronavirus; I tested positive for the coronavirus; throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 27 year-old male patient received bnt162b2 (BNT162B2), administration date 18Aug2021 (Lot number: GW0183) at the age of 26 years as dose 2, single and (Lot number: EEW0183) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Peanuts" (unspecified if ongoing); "Known allergies: tree nuts" (unspecified if ongoing). There were no concomitant medications.The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 05Jan2022, outcome "recovering" and all described as "I tested positive for the coronavirus"; OROPHARYNGEAL DISCOMFORT (non-serious) with onset 05Jan2022, outcome "recovering", described as "throat". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (05Jan2022) positive; (unspecified date) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19, oropharyngeal discomfort. Clinical course: The patient had no taken other vaccine in four weeks and no other mediation in two weeks. The patient had no covid prior vaccination. The patient was tested for Covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Fever, very painful 9/10 muscle pain x 3 days , joint swelling, inability to move fingers/toes, persistent arm pain at injection site for over 5 days now.
Headache, Myalgia, Arthralgia, NauseaVomiting, CHILLS, FATIGUE
Rash on body (diagnosed as pityriasis rosea by doctor) which spread to other areas; fatigue; chills; sneezing; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 21Mar2021 at 12:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced rash on body (diagnosed as pityriasis rosea by doctor) which spread to other areas, fatigue, chill and sneezing. The events pityriasis rosea, fatigue, chills and sneezing resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pityriasis rosea, fatigue, chills and sneezing and included treatment with Valtrax. The clinical outcome of the events pityriasis rosea, fatigue, chills and sneezing was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Body aches; Fever; Chills; Nausea; This is a spontaneous report from a contactable healthcare professional (HCP), the patient. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) solution for injection in the left arm on 06Jan2021 at 09:15 (at the age of 37-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included IBS (irritable bowel syndrome) and known allergies possibly penicillin related drugs. Concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 06Jan2021 at 21:00, the patient experienced body aches, fever, chills, and nausea. No treatment was provided for the events body aches, fever, chills, and nausea. The outcome of the events body aches, fever, chills, and nausea was recovering. Since the vaccination, the patient has not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Fever to 104 on 7JUN - 8JUN accompanied by appearance of red raised coalesce rash spreading fr face to arms to legs; Seen on 11JUN91 w/resolution of rash on face; no involvement of Oropharynx, palms, soles;
she had very adverse reactions for three days in which she had to call off work and was on deaths door; This is a spontaneous report from a contactable consumer or other non hcp. A 63-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date was not reported), dose 1 via an unspecified route of administration on 18Apr2021, as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that patient received the first dose of the Pfizer Covid-19 vaccine on 18Apr2021 and she is scheduled to receive the second dose tomorrow. She "had very adverse reactions for three days" in which she had to call off work and was "on deaths door. She stated that it has been over 4 weeks since she had the vaccine due to being uncertain if she was going to receive the second dose. She was originally scheduled on Mother's Day for her second injection. She was asking that, since it has been more than 3 weeks apart, is it even worth it to get the shot. She already spoke with her HCP and she is adamant about caller receiving the second dose. The outcome of the event was unknown.  Follow up are needed. Information about batch/Lot number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 38-year-old male patient received BNT162b2 (BNT162B2), on 16Dec2021 as dose 3 (booster), single (Lot number: ff2589) at the age of 37 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: high blood pressure. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient was asked if he was taking any other medication or product to which the patient said yes but the name was not provided. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlocvid orally with lot number gc3409 from 14Jun2022 to Jun2022.  No follow-up attempts are possible. No further information is expected.
Pale, diaphoretic and temporary loss of vision for approximately 5-7 minutes.
PATIENT STATES THAT AFTER HER VACCINATION, HER LEFT ARM WAS SWELLING, REDNESS, SORENESS, AND SHE HAS A FEVER. ON SUNDAY SHE DECIDED TO GO TO THE ER WAS RECEIVED IV ANTIBIOTICS. HER SYMPTOMS ALL SUBSIDED 2 DAYS AFTER SHE RECEIVED TREATMENTS FROM THE ER.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. Information regarding the patients' concurrent conditions and medical conditions was not provided. On an unspecified date starting on or after 31-MAR-2016, the patients were administered an unspecified number of improperly stored doses of ROTATEQ, orally liquid, (lot # L035276, its expiration date: 09-JUN-2017; lot #L037924, its expiration date: 22-JUN-2017) (route, dose and frequency were not reported). Information regarding the patient's concomitant medication was not provided. The temperature was 33 degrees F and the time frame: 13 hours and 30 minutes. Therefore, there was not a previous temperature excursion and the call was not because of a data logger. Additionally, no adverse effects were reported. This is one of several reports concerning the same reporter. (MARRS # 1605USA008485 and MARRS # 1604USA017966). Additional information has been requested.
Pt received a Dip/Tet injection in L deltoid on 01/05/05, now presents with L upper arm muscle weakness and decreased ROM.
2 red spots appeared in left eye the evening the immunization was administered. By the next morning the entire eye was red. There was no pain and no loss of vision. Appears to be ocular hyperemia.
13AUG pt recv vax 430PM;vomiting began 6PM on 13AUG;that noc pt vomited x2, had chills (temp was not taken); 14AUG97 in AM no vomiting, no temp no h/a, no muscle/joint aches but pt c/o d;
Patient received his first dose tonight. Shortly after he came to the counter complaining of being light headed. He was instructed to sit down and take some deep breaths. Within seconds he tipped his head back and had passed out. EMTs came on site shortly after he came to. He was checked out and given the all-clear.
Constant ringing in both ears that became worse over time since the first shot.  Exact date not known, I expected it to be a temporary issue.
Nurse administering vaccine states needle/syringe came apart during administration. She is unable to state whether or not less than half or more than half of vaccine administered.
Syncopal episode with sudden onset upper abdominal pain ten minutes prior, loss of consciousness for approximately 60 seconds accompanied by tonic movements. Alert and oriented upon waking, weakness and tingling in hands lasted ten minutes after syncopal episode.
Vaccine administered to patient less than 18 years old.  Guardian present at time of administration. Consent obtained verbally and in writing prior to administration.
only ever got one flu shot and I was so sick with the flu afterward.; only ever got one flu shot and I was so sick with the flu afterward; Initial information received on 23-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer/ non-healthcare professional via social media.  This case involves patient (unspecified gender and age) who got one flu shot and was so sick (illness) with the flu afterward (influenza) while he/she received vaccine Influenza Vaccine.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient got one flu shot and was so sick (illness) with the flu afterward (influenza) (non-serious).  It was not reported if the patient received any corrective treatment. At the time of reporting, outcome of the events was unknown. There will be no information available regarding batch number in this case.
intense muscle pain; ntense joint pain; Chills; Fever; Some nausea; Mild headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Some nausea) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history information was reported.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue) had resolved.            No concomitant medication was provided Treatment received : phenergan
Shingles; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PYREXIA (Fever). On 07-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). On 01-Apr-2021, PYREXIA (Fever) had resolved. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Tongue tingling & Swelling - 9:00 hoarseness Itch throat 9:11- Benadryl, EPI Solumedrol, Dialed 911
Severe fatigue, SOB, DOE, airway congestion, nasal congestion, dry barking cough, sore throat, body aches, fever, diarrhea, bronchitis per CXR at immediate care facility where rapid PCR COVID test was negative. I was treated with Serovent inhaler for 10 days, Z-Pack to prevent pneumonia, and cough suppressant. I stayed home from work until the following Friday 1/22/21 because I am the Infection Preventionist RN for my hospital and I was needed on duty.
High fever, 105.1.  Racing heart, dizziness, headache and nausea.  10/14/12 I still feel a bit worn out from the fever but am doing better.
The day after dose 1 vaccine, I started having my muscles lock up, making it hard to move. It started in my arm then moved to my limbs and back. I started having a fever of 102.0 and chills. This lasted for about 2 weeks. I also had fatigue, body aches and a poor appetite. I did not seek care from a doctor. I had searched online and these symptoms were expected. I started noticing 2 weeks after the vaccine that I started gradually feeling better.
The entire outer forearm, starting about an inch below the vaccination site, all the way down to the elbow, turned red and would itch.   This began the next day after the vaccination and has persisted for the past six days. I have applied Hydrocortisone creme 1% two or three times every day  and that helps relieve the itch, but the swelling and redness continues.
Soon after the injection he noted a slight fever, body pain, migraine, slight nausea. These symptoms lasted for 2 days
Very reddish purple rash on my breasts and stomach. Slept from approximately 10 am on day of vaccine until the next morning with just getting up to use restroom.
This spontaneous report as received from a patient's grandfather refers to a 2 month old patient of unknown gender. On 26-JUL-2017, the patient was vaccinated with ROTATEQ dose 1, oral (lot# and expiry date were not provided) for prophylaxis. As of the reporting time, the patient did not receive the second dose of ROTATEQ. According to the prescribing information, the patient should have received the second dose of vaccine between weeks 4 and 10, which was by 04-OCT-2017. The patient did not experience any side effects. Product quality complaint was not involved.
Information has been received from a physician concerning a patient (age and gender unknown) who was vaccinated with a dose of Zostavax (Oka/Merck).  Subsequently the patient experienced patient broke out in chicken pox after receiving Zostavax (Oka/Merck).  The outcome of the patient was unknown.  No product quality complaint.  Additional information has been requested.
The vaccine was recorded as given 9/16/11 as above, however the emergency room note states that patient received the vaccine on 9/13/11.
Patient had 1 episode of falling at home secondary to generalized weakness.  Patient will be admitted to the hospital for  COVID positive, adult failure to thrive and Acute Kidney Injury.
Vaccine was administered on day 72 after being placed in refrigerator. No adverse events reported.
All Lymphnodes in body swelled to size of ping pong ball, hives all over skin, fever of 103.5 for three days. Now, 8 months later, I have all symptoms of Covid including no-taste, my partner who?s with me tested positive, and I haven?t tested positive after six tests.
The onset of symptoms was on July 10 with tiredness and slight headache. By day 2, I had a raging sore throat, thick mucus, headache, and some chills. I did not know what the temperature was. It didn?t feel like a normal cold, so I took a COVID-19 test and it came back positive. The sore throat was bad and lasted around 5 to 6 days. The congestion I still have right now. There are some headaches even on day 10. No GI symptoms, no loss of taste or smell. No shortness of breath or anything. I did have some ear pain with the sore throat. I self-medicated over the counter with Dayquil. I took Nyquil at night. I also alternated with ibuprofen for the pain of the sore throat. I stayed hydrated, rested, and quarantined. Today is day 10 and I?m on half doses of the medications. No more ibuprofen and no sore throat or ear pain. I am getting better. The only thing really is congestion now. In the process of recovering, not fully there, but getting better.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Sep2022 as dose 3 (booster), single (Lot number: 9M9693) at the age of 65 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Lot number: 030A21A), in left arm and on 07Nov2021 as dose 2, single (Lot number: FH8020), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: METOPROLOL, start date: 14Sep2018; LISINOPRIL, start date: 14Sep2018; SIMVASTATIN, start date: 14Sep1992. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures included Paxlovid from 10Sep2023 to 14Sep2023 were taken as a result of drug ineffective, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300306423 same patient/drug, different dose/event;
This spontaneous report as received from a register nurse refers to a 5 months infant, of unknown gender. Medical history and concurrent conditions were not reported. On 03-FEB-2014, the patient was vaccinated with dose 3 of ROTATEQ lot #J007283; expiration date: 27-SEP-2014 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored ROTATEQ was administered to patient. No adverse effects reported. The nurse reported that vaccine dose received by patient was a vaccine improperly stored as follows: On 13-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, ROTATEQ the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
urticarial rash on her abdomen and her legs; This case was reported by a pharmacist via call center representative and described the occurrence of urticarial rash in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number AC79X, expiry date 17th October 2021) for prophylaxis.   On 6th September 2019, the patient received the 1st dose of Shingrix .5 ml. On 10th September 2019, 4 days after receiving Shingrix, the patient experienced urticarial rash. On an unknown date, the outcome of the urticarial rash was not recovered/not resolved.   It was unknown if the reporter considered the urticarial rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and developed an urticarial rash on her abdomen and her legs. The reporter consented to follow up. The caller did not provide any additional information.
pt had episode of poor feeding & crying w/crampy quality 3 days p/vax;seen in clinic, no cause identified resolved p/ 3 days;
I26.99 ACUTE PULMONARY EMBOLISM 7/20/2022 HEMORRHAGIC D/O DUE EXTRINSIC CIRC ANTICOAGULANT